Javascript must be enabled to continue!
Prevalence and prognosis of non-dilated left ventricular cardiomyopathy in patients referred for cardiac magnetic resonance
View through CrossRef
Abstract
Background
The European Society of Cardiology recently identified non-dilated left ventricular cardiomyopathy (NDLVC) as a distinct clinical entity. This study aimed to determine the prevalence and prognosis of NDLVC in a specific cohort.
Materials and methods
This retrospective cohort analysis included patients referred for routine cardiac magnetic resonance (CMR) and who underwent stress myocardial perfusion or viability assessment from September 2017 to July 2020. Patients with coronary artery disease (CAD) from history or CMR imaging were excluded. Participants were categorized into dilated cardiomyopathy (DCM), NDLVC, and control groups. NDLVC was defined as the presence of non-ischemic LGE or isolated global left ventricular hypokinesia without left ventricular dilatation. The primary endpoints were all-cause mortality or heart failure events.
Results
Among 4377 CMR patients, 2278 patients remain after the exclusion. Mean age was 66.3 ± 13.2 years, and 60.4% were females. Upon categorization, there were 1996 controls (87.6%), 172 DCM patients (7.6%), and 110 NDLVC patients (4.8%). Among the NDLVC patients, 64 patients (58.2%) had non-ischemic LGE, which included mid-wall, subepicardial, patchy and right ventricular insertion types. Over a median follow-up of 37.5 months, DCM patients exhibited higher rates of composite outcomes than NDLVC and control patients. Likewise, NDLVC patients also had significantly greater rates of composite outcomes and heart failure events than the controls.
Conclusion
NDLVC had a prevalence of 2.5% among routine stress or viability CMR cases and had a significantly higher rate of clinical outcomes than the controls but lower than DCM patients. These findings underscore the distinct clinical significance of NDLVC.
Key Points
Question
What is the prevalence and clinical prognosis of non-dilated left ventricular cardiomyopathy (NDLVC) in patients undergoing routine stress or viability cardiac MRI?
Findings
NDLVC was present in 2.5% of patients undergoing routine stress or viability cardiac MRI and was associated with worse clinical outcomes than controls, but more favorable than dilated cardiomyopathy.
Clinical relevance
Identifying NDLVC on routine cardiac magnetic resonance (CMR) provides prognostic value, helping to recognize patients at increased risk of heart failure events despite preserved left ventricular size.
Graphical Abstract
Springer Science and Business Media LLC
Title: Prevalence and prognosis of non-dilated left ventricular cardiomyopathy in patients referred for cardiac magnetic resonance
Description:
Abstract
Background
The European Society of Cardiology recently identified non-dilated left ventricular cardiomyopathy (NDLVC) as a distinct clinical entity.
This study aimed to determine the prevalence and prognosis of NDLVC in a specific cohort.
Materials and methods
This retrospective cohort analysis included patients referred for routine cardiac magnetic resonance (CMR) and who underwent stress myocardial perfusion or viability assessment from September 2017 to July 2020.
Patients with coronary artery disease (CAD) from history or CMR imaging were excluded.
Participants were categorized into dilated cardiomyopathy (DCM), NDLVC, and control groups.
NDLVC was defined as the presence of non-ischemic LGE or isolated global left ventricular hypokinesia without left ventricular dilatation.
The primary endpoints were all-cause mortality or heart failure events.
Results
Among 4377 CMR patients, 2278 patients remain after the exclusion.
Mean age was 66.
3 ± 13.
2 years, and 60.
4% were females.
Upon categorization, there were 1996 controls (87.
6%), 172 DCM patients (7.
6%), and 110 NDLVC patients (4.
8%).
Among the NDLVC patients, 64 patients (58.
2%) had non-ischemic LGE, which included mid-wall, subepicardial, patchy and right ventricular insertion types.
Over a median follow-up of 37.
5 months, DCM patients exhibited higher rates of composite outcomes than NDLVC and control patients.
Likewise, NDLVC patients also had significantly greater rates of composite outcomes and heart failure events than the controls.
Conclusion
NDLVC had a prevalence of 2.
5% among routine stress or viability CMR cases and had a significantly higher rate of clinical outcomes than the controls but lower than DCM patients.
These findings underscore the distinct clinical significance of NDLVC.
Key Points
Question
What is the prevalence and clinical prognosis of non-dilated left ventricular cardiomyopathy (NDLVC) in patients undergoing routine stress or viability cardiac MRI?
Findings
NDLVC was present in 2.
5% of patients undergoing routine stress or viability cardiac MRI and was associated with worse clinical outcomes than controls, but more favorable than dilated cardiomyopathy.
Clinical relevance
Identifying NDLVC on routine cardiac magnetic resonance (CMR) provides prognostic value, helping to recognize patients at increased risk of heart failure events despite preserved left ventricular size.
Graphical Abstract.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Association between Bisphenol A exposure and dilated cardiomyopathy
Association between Bisphenol A exposure and dilated cardiomyopathy
Abstract
Background
Evidence has identified bisphenol A to have detrimental environmental and health effects. There are f...
The role of right ventricular function in paediatric idiopathic dilated cardiomyopathy
The role of right ventricular function in paediatric idiopathic dilated cardiomyopathy
AbstractIntroductionThe prevalence of right ventricular dysfunction in idiopathic dilated cardiomyopathy is incompletely studied in children. Furthermore, right ventricular functio...
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
Background
Takotsubo cardiomyopathy, also known as stress cardiomyopathy and broken heart syndrome, is a transient, non-ischemic cardiomyopathy marked by revers...
STUDY THE LEFT VENTRICULAR FUNCTION WITH SPECKLE TRACKING IMAGING IN PATIENTS WITH DILATED CARDIOMYOPATHY AFTER TREATMENT WITH PHOSPHODIESTERASE INHIBITORS-OLPRINONE
STUDY THE LEFT VENTRICULAR FUNCTION WITH SPECKLE TRACKING IMAGING IN PATIENTS WITH DILATED CARDIOMYOPATHY AFTER TREATMENT WITH PHOSPHODIESTERASE INHIBITORS-OLPRINONE
Objectives
The aim of this study is to compare the left ventricular systolic and diastolic function with spackle tracking imaging (STI) in patients with chronic c...
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiomyopathies with left ventricular hypertrophy phenotype: prevalence of cardiac amyloidosis and clinical characteristics of patients
Cardiac amyloidosis was long considered a rare disease, primarily affecting the elderly. However, recent studies have demonstrated a higher prevalence, highlighting the need for fu...
Case Report: Ventricular preexcitation-induced dilated cardiomyopathy improved by the pharmacologic suppression of ventricular preexcitation in three infants, and literature review
Case Report: Ventricular preexcitation-induced dilated cardiomyopathy improved by the pharmacologic suppression of ventricular preexcitation in three infants, and literature review
The therapy of ventricular preexcitation-induced dilated cardiomyopathy in very small infants or infants with a high risk of ablation is tough and related articles are rare. Effect...

